fbpx
Woman having light therapy

Therapy shows hope for MS fatigue in small study

Therapy shows hope for MS fatigue in small studyPublished: 15 December 2022 A drug-free approach to multiple sclerosis (MS) fatigue showed some promise in a recent study. Participants used a bright light therapy (BLT) machine for 30 minutes every day for two weeks. In the main group, the light worked
Read More

These foods found to be strongly linked to depression in MS

These foods found to be strongly linked to depression in MSPublished: 07 December 2022 A new study has found that people with multiple sclerosis (MS) who eat a diet full of acidic foods, such as meat, cheese and grains, and lacking in alkaline foods such as vegetables and fruit, have
Read More

Hold the sherry – booze may hinder MS treatment effectiveness

Hold the sherry – booze may hinder MS treatment effectivenessPublished: 06 December 2022 Drinking alcohol around the same time as taking multiple sclerosis (MS) treatment Tecfidera (dimethyl fumarate) may limit the drug’s effectiveness according to a new study done on mice. Mice were given alcohol ten minutes before their medication
Read More
Gut bacteria and MS

The MS treatment shown to boost good gut bacteria

The MS treatment shown to boost good gut bacteriaPublished: 02 December 2022 A disease-modifying therapy (DMT) has been found to improve gut bacteria in people with multiple sclerosis (MS). Tecfidera (dimethyl fumarate) caused a reduced proportion of pro-inflammatory gut flora and an increase in ‘good’ bacteria when taken for three
Read More

This MS drug switch means fewer relapses in study

This MS drug switch means fewer relapses in studyPublished: 30 November 2022 People with multiple sclerosis (MS) who switched from Gilenya (fingolimod) experienced fewer relapses than those who changed to Tysabri (natalizumab) or Mavenclad (cladribine) in a new study. The research included data from 1,045 patients from 26 countries. Each
Read More
Fatty acids

Dietary supplement reduced relapses in MS patients taking DMTs

Dietary supplement reduced relapses in MS patients taking DMTsPublished: 25 November 2022 A supplement called Neuroaspis plp 10 may lower relapse rates and disability progression in people with multiple sclerosis (MS) who are taking interferon beta drugs, a new small study in Greece has found. Neuroaspis plp 10 is a
Read More
MS life expectancy and disability

MS life expectancy decline linked to worse disability

MS life expectancy decline linked to worse disabilityPublished: 16 November 2022 The level of disability an MS patient experiences is linked to life expectancy, according to a new study. Researchers found that people with minimal to moderate disability could expect to live another 30 years after being diagnosed, but with
Read More
Person with diabetes

Diabetes medication effect on MS risk

Diabetes medication effect on MS risk - study reveals interesting resultsPublished: 23 November 2022 The risk of developing multiple sclerosis (MS) in people with diabetes who take anti-hyperglycemic medication (A-HgM) is reduced in young people but increased for older adults and women in particular, according to a new study. Some
Read More

Lesion clue to help predict disability progression

Lesion clue to help predict disability progressionPublished: 11 November 2022 Monitoring lesion expansion can predict disability progression in people with multiple sclerosis (MS) better than other types of lesions assessment, according to a new study. MS is caused by inflammation in the brain and spinal cord, and the damage from
Read More

Disease-modifying therapies linked to increased risk of cervical lesions in women

Disease-modifying therapies linked to increased risk of cervical lesions in womenPublished: 08 November 2022 Taking high-efficacy disease-modifying therapies (DMTs) is linked with an increased risk of abnormalities of the cervix in females with multiple sclerosis (MS), new research suggests. This information is consistent with other research which has associated DMTs
Read More